153 related articles for article (PubMed ID: 9253783)
1. Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusions: results of randomized clinical trials.
Goldberg MA
Semin Hematol; 1997 Jul; 34(3 Suppl 2):41-7. PubMed ID: 9253783
[TBL] [Abstract][Full Text] [Related]
2. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery.
Goldberg MA; McCutchen JW; Jove M; Di Cesare P; Friedman RJ; Poss R; Guilfoyle M; Frei D; Young D
Am J Orthop (Belle Mead NJ); 1996 Aug; 25(8):544-52. PubMed ID: 8871752
[TBL] [Abstract][Full Text] [Related]
3. Epoetin alfa. A bloodless approach for the treatment of perioperative anemia.
Faris PM; Ritter MA
Clin Orthop Relat Res; 1998 Dec; (357):60-7. PubMed ID: 9917701
[TBL] [Abstract][Full Text] [Related]
4. Epoetin alfa plus autologous blood donation and normovolemic hemodilution in patients scheduled for orthopedic or vascular surgery.
Tryba M
Semin Hematol; 1996 Apr; 33(2 Suppl 2):34-6; discussion 37-8. PubMed ID: 8723580
[TBL] [Abstract][Full Text] [Related]
5. Preoperative epoetin alfa vs autologous blood donation in primary total knee arthroplasty.
Deutsch A; Spaulding J; Marcus RE
J Arthroplasty; 2006 Aug; 21(5):628-35. PubMed ID: 16877146
[TBL] [Abstract][Full Text] [Related]
6. Perisurgical use of epoetin alfa in orthopedic surgery patients.
Adamson J
Semin Hematol; 1996 Apr; 33(2 Suppl 2):55-8; discussion 59. PubMed ID: 8723584
[TBL] [Abstract][Full Text] [Related]
7. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
Patton J; Kuzur M; Liggett W; Miranda F; Varsos H; Porter L
Oncologist; 2004; 9(1):90-6. PubMed ID: 14755018
[TBL] [Abstract][Full Text] [Related]
8. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.
Scott SN; Boeve TJ; McCulloch TM; Fitzpatrick KA; Karnell LH
Laryngoscope; 2002 Jul; 112(7 Pt 1):1221-9. PubMed ID: 12169903
[TBL] [Abstract][Full Text] [Related]
9. Autologous blood donation plus epoetin alfa in nonanemic orthopedic surgery patients.
Baudoux E
Semin Hematol; 1996 Apr; 33(2 Suppl 2):31-2; discussion 33. PubMed ID: 8723579
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of perioperative epoetin alfa in patients scheduled for elective hip surgery.
Laupacis A
Semin Hematol; 1996 Apr; 33(2 Suppl 2):51-3; discussion 54. PubMed ID: 8723583
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
[TBL] [Abstract][Full Text] [Related]
12. Epoetin alfa as an adjunct to autologous blood donation in patients with a low hematocrit scheduled for elective orthopedic surgery.
Adamson J
Semin Hematol; 1996 Apr; 33(2 Suppl 2):15-6; discussion 17. PubMed ID: 8723575
[TBL] [Abstract][Full Text] [Related]
13. Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.
Mercuriali F
Semin Hematol; 1996 Apr; 33(2 Suppl 2):18-20; discussion 21. PubMed ID: 8723576
[TBL] [Abstract][Full Text] [Related]
14. Epoetin alfa plus autologous blood donation in patients with a low hematocrit scheduled to undergo orthopedic surgery.
Tryba M
Semin Hematol; 1996 Apr; 33(2 Suppl 2):22-4; discussion 25-6. PubMed ID: 8723577
[TBL] [Abstract][Full Text] [Related]
15. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
Voravud N; Sriuranpong V; Suwanrusme H
J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
[TBL] [Abstract][Full Text] [Related]
16. Patients previously transfused or treated with epoetin alfa at low baseline hemoglobin are at higher risk for subsequent transfusion: an integrated analysis of the Canadian experience.
Quirt I; Kovacs M; Couture F; Turner AR; Noble M; Burkes R; Dolan S; Plante RK; Lau CY; Chang J
Oncologist; 2006 Jan; 11(1):73-82. PubMed ID: 16401716
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer. Implications for use in gynecologic surgery.
Stovall TG
J Reprod Med; 2001 May; 46(5 Suppl):531-8. PubMed ID: 11396387
[TBL] [Abstract][Full Text] [Related]
18. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy.
Chun TY; Martin S; Lepor H
Urology; 1997 Nov; 50(5):727-32. PubMed ID: 9372883
[TBL] [Abstract][Full Text] [Related]
19. Epoetin alfa increases the volume of autologous blood donated by patients scheduled to undergo orthopedic surgery.
Mercuriali F
Semin Hematol; 1996 Apr; 33(2 Suppl 2):10-2; discussion 13-4. PubMed ID: 8723574
[TBL] [Abstract][Full Text] [Related]
20. Potential of epoetin alfa in patients in autologous blood donation programs for orthopedic surgery.
McClelland B
Semin Hematol; 1996 Apr; 33(2 Suppl 2):2-3; discussion 4. PubMed ID: 8723572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]